Earlybird Venture Capital

Portfolio Co Investors 2026 for Earlybird Venture Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Earlybird Venture Capital accounts for 13 tracked companies with verified cap-table data, 13 of which disclose round sizes totalling $1.2B. The median disclosed raise is $67M, and the largest is Marvel Fusion at $418M, ahead of Grey Wolf Therapeutics ($131M) and ENYO Pharma ($102M).

The names that recur most often on these co-invested cap tables are Earlybird Venture Capital (13 companies), Andera Partners (4 companies), HV Capital (2 companies), Bpifrance (2 companies), Sofinnova Partners (2 companies), Creandum (2 companies). By latest disclosed round, the market skews Series B (5), Series C (3), Series A (3), Series D (1).

Best funded Earlybird Venture Capital companies

  1. Marvel Fusion — $418M (latest: Series B)
  2. Grey Wolf Therapeutics — $131M (latest: Series B)
  3. ENYO Pharma — $102M (latest: Series C)
  4. Miracor Medical — $97M (latest: Series D)
  5. cargo.one — $84M (latest: Series B)
  6. 11x — $76M (latest: Series B)
  7. MYNE Homes — $67M (latest: Series A)
  8. GOURMEY — $59M (latest: Series A)
  9. Ariceum Therapeutics — $48M (latest: Series A)
  10. LIQID Investments — $46M (latest: Series C)
  11. Shape Memory Medical — $38M (latest: Series C)
  12. INNOVO by Atlantic Therapeutics — $32M (latest: Series B)
  13. HAYA Therapeutics — $25M (latest: Seed)

Earlybird Venture Capital — related firms and companies (56)

Earlybird Venture Capital alternatives · All research reports